In a large retrospective analysis using measurements of thousands of plasma proteins in primary and secondary event populations, scientists from deCODE genetics and collaborators from U.S., Denmark and Iceland, reported today in JAMA how they employed AI to develop a protein score to predict major atherosclerotic cardiovascular disease events (ASCVD).
Leave A Comment